| Mr Matthew Favinger, MS | |
|
28302 Gravel Hill Rd, Millsboro, DE 19966-3956 | |
| (302) 934-1471 | |
| (302) 934-9687 |
| Full Name | Mr Matthew Favinger |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 28302 Gravel Hill Rd, Millsboro, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912040452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 02-0000122 (Delaware) | Primary |
| Provider Name | Hearing Aid Associates, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952672339 PECOS PAC ID: 0042478265 Enrollment ID: O20120220000729 |
News Archive
Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.
As the 16th anniversary of Hurricane Katrina on Aug. 29 approached, New Orleans residents were bracing for another disaster, Hurricane Ida. This year, similar to last, the country will be hit by an above-average number of extreme weather events, including major hurricanes, flooding, and wildfires.
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
Many terminal cancer patients are not getting adequate pain relief early enough, according to a University of Leeds study.
With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Matthew Favinger, MS 28302 Gravel Hill Rd, Millsboro, DE 19966-3956 Ph: (302) 934-1471 | Mr Matthew Favinger, MS 28302 Gravel Hill Rd, Millsboro, DE 19966-3956 Ph: (302) 934-1471 |
News Archive
Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.
As the 16th anniversary of Hurricane Katrina on Aug. 29 approached, New Orleans residents were bracing for another disaster, Hurricane Ida. This year, similar to last, the country will be hit by an above-average number of extreme weather events, including major hurricanes, flooding, and wildfires.
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
Many terminal cancer patients are not getting adequate pain relief early enough, according to a University of Leeds study.
With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.
› Verified 1 days ago
Megan E Boehler, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 32034 Long Neck Rd, Millsboro, DE 19966 Phone: 302-945-8886 Fax: 302-947-9687 | |
Hearing Aid Associates, Llc Audiologist Medicare: Medicare Enrolled Practice Location: 25255 Gravel Hill Rd, Millsboro, DE 19966 Phone: 302-934-1471 Fax: 302-934-9687 |